Picture of Abnova Taiwan logo

4133 Abnova Taiwan Income Statement

0.000.00%
tw flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapFalling Star

Annual income statement for Abnova Taiwan, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue414456451412382
Cost of Revenue
Gross Profit185214197201174
Selling / General / Administrative Expenses
Research And Development
Other Operating Expenses
Total Operating Expenses412399408347335
Operating Profit2.6457.743.864.447.2
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes0.984936.39548.5
Provision for Income Taxes
Net Income After Taxes3.2636.528.474.843.7
Net Income Before Extraordinary Items
Net Income3.2636.528.474.843.7
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income3.2636.528.474.843.7
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.0540.6030.4791.230.772
Dividends per Share